These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 19020545

  • 1. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
    Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG, International Myeloma Working Group.
    Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY, Suh JT, Lee HJ, Yoon HJ, Lee WI.
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [Abstract] [Full Text] [Related]

  • 3. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M, Lazăr V, Coriu D.
    Roum Arch Microbiol Immunol; 2011 Sep; 70(1):15-22. PubMed ID: 21717807
    [Abstract] [Full Text] [Related]

  • 4. Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders.
    Vermeersch P, Vercammen M, Holvoet A, Vande Broek I, Delforge M, Bossuyt X.
    Clin Chim Acta; 2009 Dec; 410(1-2):54-8. PubMed ID: 19778527
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
    Abadie JM, Bankson DD.
    Ann Clin Lab Sci; 2006 Dec; 36(2):157-62. PubMed ID: 16682511
    [Abstract] [Full Text] [Related]

  • 11. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.
    Graziani MS, Merlini G.
    Expert Rev Mol Diagn; 2014 Jan; 14(1):55-66. PubMed ID: 24308339
    [Abstract] [Full Text] [Related]

  • 12. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.
    Tate JR, Mollee P, Dimeski G, Carter AC, Gill D.
    Clin Chim Acta; 2007 Feb; 376(1-2):30-6. PubMed ID: 16945362
    [Abstract] [Full Text] [Related]

  • 13. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA, Plant T, Drayson M, Cockwell P, Kountouri M, Basnayake K, Harding S, Bradwell AR, Mead G.
    BMC Nephrol; 2008 Sep 22; 9():11. PubMed ID: 18808676
    [Abstract] [Full Text] [Related]

  • 14. Complementarily of urine analysis and serum free light chain assay for assessing response treatment response: illustrated by three case examples.
    Levinson SS.
    Clin Chim Acta; 2011 Nov 20; 412(23-24):2206-10. PubMed ID: 21864518
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K, Itoh J, Sugiura I, Tsushita K, Kosugi H, Nagura E.
    Rinsho Ketsueki; 2006 Apr 20; 47(4):303-9. PubMed ID: 16715965
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA, Abraham RS, Dispenzieri A, Lust JA, Kyle RA.
    Clin Chem; 2005 May 20; 51(5):878-81. PubMed ID: 15774572
    [Abstract] [Full Text] [Related]

  • 18. [Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma].
    Maruyama Y, Hayashi T, Ikeda H, Yasui H, Ishida T, Shinomura Y.
    Rinsho Ketsueki; 2013 Jan 20; 54(1):122-6. PubMed ID: 23391656
    [Abstract] [Full Text] [Related]

  • 19. [Serum free light chains for diagnosis and follow-up of multiple myeloma].
    Jung S, Kim M, Lim J, Kim Y, Han K, Min CK, Min WS.
    Korean J Lab Med; 2008 Jun 20; 28(3):169-73. PubMed ID: 18594166
    [Abstract] [Full Text] [Related]

  • 20. Serum free light chains: diagnostic and prognostic value in multiple myeloma.
    Sthaneshwar P, Nadarajan V, Maniam JA, Nordin N, Gin Gin G.
    Clin Chem Lab Med; 2009 Jun 20; 47(9):1101-7. PubMed ID: 19728852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.